HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Benzoyl peroxide label warning

This article was originally published in The Rose Sheet

Executive Summary

Benzoyl peroxide label warning: NDMA asks for more time to comment on FDA's proposed rule on benzoyl peroxide product labeling. Published Feb. 17, the proposal would require all topically applied acne products containing benzoyl peroxide to carry label statements warning consumers to avoid "unnecessary sun exposure" when using the product ("The Rose Sheet" Feb. 20, p. 12). NDMA said in an April 12 letter to FDA that the association has "uncovered questions about certain facts as stated in the...notice that require more time to document fully." The current comment deadline is May 18; NDMA is asking for an extension to July 17...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts